Market Perform Rating Maintained for Owens & Minor Amid Strategic Acquisitions and Financial Caution
Citi Maintains Owens & Minor(OMI.US) With Buy Rating
Citi Sticks to Their Buy Rating for Owens & Minor (OMI)
Barclays Maintains Owens & Minor(OMI.US) With Hold Rating, Maintains Target Price $23
Barclays Keeps Their Hold Rating on Owens & Minor (OMI)
Owens & Minor Analyst Ratings
Owens & Minor Analyst Ratings
Owens & Minor Analyst Ratings
Analysts Have Conflicting Sentiments on These Healthcare Companies: Ascendis Pharma (ASND), Owens & Minor (OMI) and Illumina (ILMN)
Baird Adjusts Owens & Minor Price Target to $24 From $28, Maintains Neutral Rating
Owens & Minor Analyst Ratings
Analysts' Opinions Are Mixed on These Healthcare Stocks: Owens & Minor (OMI), Idexx Laboratories (IDXX) and CytomX Therapeutics (CTMX)
Owens & Minor Analyst Ratings
Analysts' Opinions Are Mixed on These Healthcare Stocks: Owens & Minor (OMI), Bruker (BRKR) and Gilead Sciences (GILD)
Owens & Minor Analyst Ratings
Analysts Offer Insights on Healthcare Companies: Medtronic (MDT), Owens & Minor (OMI) and Warby Parker (WRBY)
Critical Insights From Owens & Minor Analyst Ratings: What You Need To Know
UBS Adjusts Owens & Minor Price Target to $27 From $26, Maintains Buy Rating
Owens & Minor Analyst Ratings
Maintaining Sell Rating on Owens & Minor: Navigating Short-Term Hurdles While Investing for Long-Term Growth